CAS: 1430114-34-3
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | 4-(2-(3-(3-Chloro-2-fluoro-6-(1H-tetrazol-1-yl)phenyl)acryloyl)-5-(4-methyl-2-oxopiperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-ca rboxamido)benzoic acid REF: 3D-FHC11434CAS: 1430114-34-3 | Min. 95% | A consultar | Sex 27 Dez 24 |
 | BMS-962212 REF: TM-T14682CAS: 1430114-34-3 | 98% | 1.113,00 €~3.458,00 € | Qua 15 Jan 25 |
4-(2-(3-(3-Chloro-2-fluoro-6-(1H-tetrazol-1-yl)phenyl)acryloyl)-5-(4-methyl-2-oxopiperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-ca rboxamido)benzoic acid
CAS:1430114-34-3
4-(2-(3-(3-Chloro-2-fluoro-6-(1H-tetrazol-1-yl)phenyl)acryloyl)-5-(4-methyl-2-oxopiperazin-1-yl)-1,2,3,4 -tetrahydroisoquinoline-1-carboxamido)benzoic acid is a drug that inhibits the thromboembolic activity of blood platelets. It …
Fórmula:
C32H28ClFN8O5
Pureza:
Min. 95%
Peso molecular:
659.1 g/mol
Ref: 3D-FHC11434
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada em Estados Unidos, Sexta-feira 27 de Dezembro de 2024
BMS-962212
CAS:1430114-34-3
BMS-962212: reversible, selective FXIa blocker, well-tolerated, quick PD effect, rapid clearance, alters clotting time/activity.
Fórmula:
C32H28ClFN8O5
Pureza:
98%
Cor e Forma:
Solid
Peso molecular:
659.07
Ref: TM-T14682
| 25mg | 1.967,00 € | ||
| 50mg | 2.598,00 € | ||
| 100mg | 3.458,00 € |
Entrega estimada em Estados Unidos, Quarta-feira 15 de Janeiro de 2025
